Latest Insider Transactions at Orthofix Medical Inc. (OFIX)
This section provides a real-time view of insider transactions for Orthofix Medical Inc. (OFIX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Orthofix Medical Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Orthofix Medical Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 15
2024
|
Jorge Andres Cedron CLO |
BUY
Grant, award, or other acquisition
|
Direct |
28,648
+50.0%
|
$372,424
$13.09 P/Share
|
|
Apr 11
2024
|
Kimberley A. Elting President, Global Orthopedics |
SELL
Payment of exercise price or tax liability
|
Direct |
2,938
-1.25%
|
$38,194
$13.95 P/Share
|
|
Apr 08
2024
|
Catherine M Burzik |
SELL
Payment of exercise price or tax liability
|
Direct |
47,486
-29.63%
|
$664,804
$14.23 P/Share
|
|
Apr 01
2024
|
Kimberley A. Elting President, Global Orthopedics |
SELL
Payment of exercise price or tax liability
|
Direct |
2,031
-0.86%
|
$28,434
$14.06 P/Share
|
|
Apr 01
2024
|
Geoffrey C Gillespie CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
70
-0.17%
|
$980
$14.06 P/Share
|
|
Mar 15
2024
|
Geoffrey C Gillespie CAO |
BUY
Grant, award, or other acquisition
|
Direct |
3,639
+8.18%
|
$47,307
$13.74 P/Share
|
|
Feb 01
2024
|
Kimberley A. Elting President, Global Orthopedics |
SELL
Payment of exercise price or tax liability
|
Direct |
2,015
-0.84%
|
$28,210
$14.27 P/Share
|
|
Jan 31
2024
|
Michael Finegan |
BUY
Grant, award, or other acquisition
|
Direct |
8,350
+50.0%
|
$108,550
$13.89 P/Share
|
|
Jan 31
2024
|
Alan Lee Bazaar |
BUY
Grant, award, or other acquisition
|
Direct |
8,936
+50.0%
|
$116,168
$13.89 P/Share
|
|
Jan 31
2024
|
Charles R. Kummeth |
BUY
Grant, award, or other acquisition
|
Direct |
8,350
+26.34%
|
$108,550
$13.89 P/Share
|
|
Jan 15
2024
|
Julie Andrews CFO |
BUY
Grant, award, or other acquisition
|
Direct |
32,967
+50.0%
|
$428,571
$13.65 P/Share
|
|
Jan 08
2024
|
Massimo Calafiore President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
141,084
+50.0%
|
$1,834,092
$13.29 P/Share
|
|
Jan 08
2024
|
Kevin J. Kenny President of Global Spine |
SELL
Payment of exercise price or tax liability
|
Direct |
1,511
-1.03%
|
$19,643
$13.29 P/Share
|
|
Jan 08
2024
|
Kevin J. Kenny President of Global Spine |
BUY
Exercise of conversion of derivative security
|
Direct |
5,959
+3.89%
|
-
|
|
Jan 08
2024
|
Geoffrey C Gillespie CAO |
BUY
Grant, award, or other acquisition
|
Direct |
4,703
+11.17%
|
$61,139
$13.29 P/Share
|
|
Jan 08
2024
|
Kimberley A. Elting President, Global Orthopedics |
SELL
Grant, award, or other acquisition
|
Direct |
18,811
-7.3%
|
$244,543
$13.29 P/Share
|
|
Jan 05
2024
|
Kevin J. Kenny President of Global Spine |
SELL
Payment of exercise price or tax liability
|
Direct |
2,955
-2.05%
|
$35,460
$12.67 P/Share
|
|
Jan 05
2024
|
Geoffrey C Gillespie CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
459
-1.39%
|
$5,508
$12.67 P/Share
|
|
Jan 05
2024
|
Kimberley A. Elting President, Global Orthopedics |
SELL
Payment of exercise price or tax liability
|
Direct |
5,228
-2.32%
|
$62,736
$12.67 P/Share
|
|
Jan 03
2024
|
Kimberley A. Elting President, Global Orthopedics |
SELL
Payment of exercise price or tax liability
|
Direct |
1,778
-0.78%
|
$21,336
$12.96 P/Share
|
|
Dec 18
2023
|
Alan Lee Bazaar |
SELL
Sale (or disposition) back to the issuer
|
Direct |
8,936
-100.0%
|
-
|
|
Dec 15
2023
|
Geoffrey C Gillespie CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
24
-0.07%
|
$288
$12.12 P/Share
|
|
Dec 12
2023
|
Alan Lee Bazaar |
BUY
Grant, award, or other acquisition
|
Direct |
8,936
+50.0%
|
-
|
|
Dec 04
2023
|
Kevin J. Kenny President of Global Spine |
SELL
Payment of exercise price or tax liability
|
Direct |
609
-0.42%
|
$6,090
$10.79 P/Share
|
|
Nov 17
2023
|
Kimberley A. Elting President, Global Orthopedics |
BUY
Grant, award, or other acquisition
|
Direct |
47,664
+17.34%
|
-
|
|
Oct 15
2023
|
Catherine M Burzik |
BUY
Grant, award, or other acquisition
|
Direct |
120,676
+43.21%
|
-
|
|
Oct 15
2023
|
Puja Leekha CECO & Interim CLO |
BUY
Grant, award, or other acquisition
|
Direct |
32,180
+40.48%
|
-
|
|
Oct 15
2023
|
Geoffrey C Gillespie CAO |
BUY
Grant, award, or other acquisition
|
Direct |
23,331
+41.36%
|
-
|
|
Sep 14
2023
|
James F. Hinrichs Director |
BUY
Open market or private purchase
|
Direct |
7,500
+8.01%
|
$97,500
$13.47 P/Share
|
|
Jun 19
2023
|
Wayne Burris Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,163
+38.05%
|
-
|
|
Jun 19
2023
|
Catherine M Burzik |
BUY
Grant, award, or other acquisition
|
Direct |
3,589
+8.64%
|
-
|
|
May 26
2023
|
Kevin J. Kenny President of Global Spine |
SELL
Open market or private sale
|
Direct |
3,876
-2.65%
|
$73,644
$19.0 P/Share
|
|
May 24
2023
|
Kevin J. Kenny President of Global Spine |
SELL
Open market or private sale
|
Direct |
4,367
-2.9%
|
$82,973
$19.0 P/Share
|
|
Apr 11
2023
|
Kevin J. Kenny President of Global Spine |
SELL
Payment of exercise price or tax liability
|
Direct |
1,469
-0.98%
|
$24,973
$17.77 P/Share
|
|
Apr 11
2023
|
Kimberley A. Elting President, Global Orthopedics |
SELL
Payment of exercise price or tax liability
|
Direct |
2,938
-1.63%
|
$49,946
$17.77 P/Share
|
|
Apr 04
2023
|
Kevin J. Kenny President of Global Spine |
BUY
Grant, award, or other acquisition
|
Direct |
7,449
+4.77%
|
-
|
|
Apr 03
2023
|
Kevin J. Kenny President of Global Spine |
SELL
Payment of exercise price or tax liability
|
Direct |
1,956
-1.37%
|
$31,296
$16.75 P/Share
|
|
Apr 03
2023
|
Jon Carl Serbousek Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
6,141
-1.74%
|
$98,256
$16.75 P/Share
|
|
Apr 03
2023
|
Kimberley A. Elting President, Global Orthopedics |
SELL
Payment of exercise price or tax liability
|
Direct |
2,385
-1.3%
|
$38,160
$16.75 P/Share
|
|
Mar 10
2023
|
Shweta Maniar Director |
SELL
Open market or private sale
|
Direct |
4,262
-17.51%
|
$72,454
$17.75 P/Share
|
|
Feb 28
2023
|
Keith Valentine President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,290
-4.13%
|
$325,800
$20.6 P/Share
|
|
Feb 28
2023
|
John J. Bostjancic CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,783
-3.66%
|
$113,490
$30.6 P/Share
|
|
Feb 28
2023
|
Patrick L Keran Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,792
-4.3%
|
$75,840
$20.6 P/Share
|
|
Feb 01
2023
|
Kevin J. Kenny President of Global Spine |
SELL
Payment of exercise price or tax liability
|
Direct |
2,287
-1.57%
|
$48,027
$21.54 P/Share
|
|
Feb 01
2023
|
Jon Carl Serbousek Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
5,142
-1.44%
|
$107,982
$21.54 P/Share
|
|
Feb 01
2023
|
Kimberley A. Elting President, Global Orthopedics |
SELL
Payment of exercise price or tax liability
|
Direct |
2,015
-1.09%
|
$42,315
$21.54 P/Share
|
|
Jan 30
2023
|
John J. Bostjancic CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,694
-1.61%
|
$35,574
$21.22 P/Share
|
|
Jan 30
2023
|
Keith Valentine President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,824
-1.46%
|
$122,304
$21.22 P/Share
|
|
Jan 30
2023
|
Patrick L Keran Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
999
-1.12%
|
$20,979
$21.22 P/Share
|
|
Jan 05
2023
|
Jon Carl Serbousek Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
337,206
+15.93%
|
-
|